Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Journal of Ethnopharmacology|October 11, 2005
Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cellsJiunn-Song Jiang, Chwen-Ming Shih, Sheng-Hao Wang, et al.
Depression and Anxiety|November 30, 2006
Correlations of quality of life with adverse effects of medication, social support, course of illness, psychopathology, and demographic characteristics in patients with panic disorderCheng-Fang Yen, Chun-Ya Kuo, Pei-Tzu Tsai, et al.
Frontiers in Psychiatry|August 30, 2021
Animal-Assisted Therapy in Middle-Aged and Older Patients With Schizophrenia: A Randomized Controlled TrialTzu-Ting Chen, Ton-Lin Hsieh, Mei-Li Chen, et al.
Pharmacogenetics and Genomics|April 9, 2010
Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatmentChen-Jee Hong, Ying-Jay Liou, Ya Mei Bai, et al.
Nursing Open|September 15, 2022
Are we of one mind about core competencies of nurse preceptors? A nominal group technique studyTzu-Ting Chen, Chia-Chi Hsiao, Tsui-Ping Chu, et al.
Sleep Health|July 10, 2023
Causal influence of sleeping phenotypes on the risk of coronary artery disease and sudden cardiac arrest: A Mendelian randomization analysisYen-Wei Chiu, Mei-Hsin Su, Yen-Feng Lin, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 10, 2014
Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophreniaKuan-Ju Chou, Hsing-Kang Chen, Chih-Hung Hung, et al.
JASA Express Letters|May 7, 2026
Acoustic measurements and modeling of sub-bottom layers on the summit of the Atlantis II SeamountTzu-Ting Chen, Matthew A Milone, Jason Chaytor, et al.
Molecular Psychiatry|February 20, 2025
Genetic architectures of childhood maltreatment and causal influence of childhood maltreatment on health outcomes in adulthoodTzu-Ting Chen, Chia-Yen Chen, Chao-Yu Liu, et al.
International Journal of Rheumatic Diseases|November 5, 2024
Evaluation of the potential of Ergostatrien-3β-ol for treating Sjögren's syndromePo-Chang Wu, Ya-Husan Chao, Xiang Zhang, et al.
Pageof 15